Poveda, A., Floquet, A., Ledermann, J. A., Asher, R., Penson, R. T., Oza, A. M., Korach, J., Huzarski, T., Pignata, S., Friedlander, M., Baldoni, A., Park-Simon, T., Tamura, K., Sonke, G. S., Lisyanskaya, A., Kim, J., Filho, E. A., Milenkova, T., Lowe, E. S., Rowe, P., Vergote, I., Pujade-Lauraine, E., & , (2021). olaparib Tablets as Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a BRCA1/2 Mutation (SOLO2/ENGOT-Ov21): A Final Analysis of a Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial. Obstetrical & gynecological survey, 76(9), 535–536. http://access.bl.uk/ark:/81055/vdc_100144514172.0x000049